PDS Biotechnology(美国)
PDS Biotechnology
美国PDSBiotechnologywww.pdsbiotech.comPDSBiotechnologyCorporation是一家非上市生物技术公司,致力于通过利用带阳电荷的特殊合成脂质中新发现的属性来推广新一代免疫疗法和疫苗。专有的Versamune™平台纳米技术,一旦与具体癌症相关的分子相结合,经证实与临床前癌症模式中的临床辅助治疗相比,可实现更高的肿瘤衰退率(CancerImm
unologyImmunotherapy,2008,57:(4)517-530)。Versamune™纳米技术在开发新一代免疫疗法方面实现了巨大了进步。PDSBiotechnologyCorporation正在开发治疗子宫癌、头颈癌和黑瘤等多发癌症的主打产品。该技术还被用于开发预防流行病的疫苗。PDSBiotechnologyCorporationisaprivatelyheldbiotechnologycompanyfoundedtoexploitthenewlydiscoveredpropertiesofspecificsyntheticpositivelycharged(cationic)lipidstocommercializeanewgenerationofimmunotherapiesandvaccines.TheproprietaryVersamune™platformnanotechnology,whencombinedwithspecificcancer-associatedmolecules,hasbeendemonstratedtoleadtoincreasedtumorregressionratescomparedtoleadingclinicaladjuvantsinpre-clinicalcancermodels(CancerImmunologyImmunotherapy,2008,57:(4)517-530).TheVersamune™nanotechnologypresen